Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster

Questions: Discounts, Updates etc.

Pages: 151

Price (Single): £1499

Price (Departmental): £2999

Price (Company): £4999

Publication Date: 2007-07-01

Order Online Now

Name:
Email:
Company Name:
Telephone:
Licence Type:
Payment Method:

People that purchased this report also purchased:

Contact LeadDiscovery

If you have questions about this report
To find out if you qualify for a discount
Want a more up to date version
Can't find a report that meets your needs

Search all reports

Cigarette smoking is the most important source of preventable and premature morbidity worldwide. Currently, the number of smokers across the globe is estimated at 1.3 billion. Political moves are leading to national bans of smoking in public places, with the long-term aim to reduce the cost to the health sector. But what will be the short-term spending on smoking cessation therapies?

The authors of this report believe the anti-smoking market to be worth $1.7 billion in 2007. This is a growth of 37% from the year before. Global Smoking Cessation Market Analysis & Forecasts - preparing for the first blockbuster, explains just how this market will experience growth over the medium term future. Also do you know what the drivers and restraints of the market are? This report not only reveals these, but also details what strategies can be used to maximize profits from the drivers and restraints.

The report examines key smoking cessation markets such as:

US
Japan
Canada
Germany
France
Italy
Spain
UK
Sweden
Australia

In this report each one of these markets is examined in terms of market growth and revenue. Plus we examine how current and new drug treatments will take hold in each market, plus which companies will succeed in each market.

According to the findings of this new report, the nicotine vaccine market will generate over $1 billion and Pfizer's nicotinic receptor will be the markets first blockbuster drug.

Can any of these drugs compete with the OTC market leaders? How will GSK's Zyban be effected with direct competition from Chantix/ Champix? Are there any others which can compete with this for market share or beat its dominance? This report answers that question, with an analysis of other players in the market.

The report provides in-depth market analysis upon these areas, and extensively identifies both prescription and OTC smoking cessation drugs by product type. The study also assess' the challenges faced by anti-smoking companies, and what exciting market opportunities exist in this up- and-coming therapeutic area.

Why You Must Buy This Report:

This report features tables, graphs and charts, news, insights, the latest developments and an in depth survey of the anti-smoking market with up-to-date analysis. This report is a vital addition to gaining an understanding of this profitable market sector and will give your company 'the edge' on your competitors.

With unmet medical needs this market has a growing user base, but how much will the market grow by? Enough for some products to begin to lose revenue? This report will tell you. Brought together in one easy to read, easily digested format, this report will keep you fully informed and up-to-date on the global ophthalmic pharmaceutical market.

Key questions that this report answers are:

What R&D opportunities exist for ‘new comers’?
Which current or future therapies will drive the smoking cessation market?
With 17 new drugs with new targets - which will succeed?
The key companies involved in the market and their analysis?
What are the current and future blockbusters within the smoking cessation industry?

1. Executive Summary
2. Introduction: 2.1 Smoking - Currently 1.3 Billion Smokers Worldwide; 2.2 Second-hand smoke/Passive smoking Causes Lung Cancer; 2.3 Medical Research in Smoking Related Problems; 2.4 Cigarette Smoking Signs and Symptoms; 2.5 Scope of the Report; 2.6 Aims and Objectives
3. Social, Political and Economic effects: 3.1 Current Policy & Expansion of Smoking Bans; 3.2 Can Complete Smoking Cessation Increase Healthcare Costs?; 3.3 Anti-Smoking Organizations and Their Lobby; 3.4 Tobacco Prices: A Key Strategy in Reducing Smokers; 3.5 Using Anti-Smoking Operations as a Health Promotion Campaign; 3.6 Economic Impact on the Tobacco Industry; 3.7 New Anti-Counterfeit Technology to Reduce Cigarette Smuggling
4. Can Drugs Deal With Addiction & Nicotine?: 4.1 Overcoming the Psychological Dependence that is Addiction; 4.2 What the Pharma Industry is up against if Nicotine is the Hardest Addiction to Break
5. Treatment Overview: 5.1 Smoking Cessation Aids; 5.2 Nicotine Replacement Therapy (NRT); 5.3 The Antidepressant Approach: Bupropion (Zyban); 5.4 Market Capturing by Varenicline (Chantix/ Champix); 5.5 Other Smoking Cessation Methods
6. Pipeline: 6.1 Anti-Smoking Market will be in High Demand; 6.2 Effective Agents in Pre-Clinical Stage; 6.3 Agents in Phase I; 6.4 Agents in Phase II; 6.5 Sanofi’s Dianicline in Phase III; 6.6 Acomplia (Rimonabant) has European Approval but still Waiting on FDA; 6.7 Summary of Pipeline Products
7. Future Therapies: 7.1 MAO-B Inhibitors - to Lessen the Shock of Withdrawal; 7.2 Nicotine Metabolism Inhibitors; 7.3 Vaccines to Stop Nicotine Reaching the Brain
8. The World Anti-Smoking Product Market, 2007-2012: 8.1 The Worldwide Anti-Smoking Product Market, 2007-2012; 8.2 NRTs Dominate the Anti-Smoking Products Market; 8.3 Market Drivers; 8.4 Market Restraints; 8.5 Market Opportunities - Is there enough Potential for New Products
9. Key National Markets: 9.1 North American Market; 9.2 European Market; 9.3 Asia/Australasia Market; 9.4 Latin American Market
9.5 Summary of the National Markets
10. Company Profiles: 10.1 Leading Companies
11. Conclusion
List of Tables: Table 5.1 Nicotine gum products available and 2006 sales ($m); Table 5.2 World Revenue ($m) for Nicorette, 2007-2012; Table 5.3 Nicotine Inhaler product and 2006 sales ($m); Table 5.4 Nicotine patch products available and 2006 sales ($m); Table 5.5 Nicotine lozenge products available and 2006 sales ($m); Table 5.6 Nicotine nasal spray product and 2006 sales ($m); Table 5.7 Anti-smoking product summary and 2006 sales; Table 5.8 Zyban World Revenue Forecast ($m), 2007-2012; Table 5.9 Anti-smoking therapies comparison, 2007; Table 5.10 Chantix/Champix World Revenue Forecast ($m), 2007-2012; Table 6.1 Anti-smoking products in the pre-clinical stage, 2007; Table 6.2 Anti-smoking products in Phase I, 2007; Table 6.3 Anti-smoking products in Phase II, 2007; Table 6.4 Summary of anti-smoking products in the pipeline, 2007; Table 8.1 The Worldwide Anti-Smoking Products Market Forecast ($m), 2007-2012; Table 8.2 World Anti-Smoking Products Market Forecast by Therapy ($m), 2007-2012; Table 8.3 Anti-Smoking Therapy Market Share (%), 2006, 2009, 2012; Table 9.1 The North American Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.2 The U.S Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.3 The Canadian Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.4 The European Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.5 The U.K Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.6 The French Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.7 The Swedish Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.8 The German Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.9 The Spanish Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.10 The Italian Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.11 The Asia/Australasia Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.12 The Australian Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.13 The Japanese Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.14 The Latin American Anti-Smoking Market Forecast ($m), 2007-2012; Table 9.15 Summary of Regional and Country Breakdown of the World Anti-Smoking Market ($m), 2007-2012; Table 10.1 GSK’s anti-smoking product sales ($m), 2006; Table 10.2 J&J anti-smoking product sales ($m), 2006; Table 10.3 Pfizer’s anti-smoking product sales ($m), 2006; Table 10.4 Novartis anti-smoking product sales ($m), 2006; Table 10.5 Watson anti-smoking product sales ($m), 2006
List of Graphs: Graph 5.1 Nicotine gum products and 2006 global revenue ($m); Graph 5.2 Nicorette Revenue Forecast ($m), 2007-2012; Graph 5.3 Nicorette Growth Forecast (%), 2007-2012; Graph 5.4 Nicotine patch products and 2006 global revenue ($m); Graph 5.5 Nicotine lozenge products and 2006 global revenue ($m); Graph 5.6: Zyban Revenue Forecast ($m), 2007-2012; Graph 5.7: Zyban Growth Forecast (%), 2007-2012; Graph 5.8: Chantix/Champix Revenue Forecast ($m), 2007-2012; Graph 5.9: Chantix/Champix Growth Forecast (%), 2007-2012; Graph 8.1 Total World Anti-Smoking Products Market Revenue ($m), 2007-2012; Graph 8.2 Total World Anti-Smoking Products Market Growth Rate (%), 2007-2012; Graph 9.1 The North American Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.2 The North American Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.3 Top anti-smoking product sales in the U.S market ($m), 2003-2006; Graph 9.4 The U.S Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.5 The U.S Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.6 Top anti-smoking product sales in the Canadian market ($m), 2003-2006; Graph 9.7 The Canadian Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.8 The Canadian Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.9 Top anti-smoking product sales in the UK market ($m), 2003-2006; Graph 9.10 The U.K Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.11 The U.K Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.12 Top anti-smoking product sales in the French market ($m), 2003-2006; Graph 9.13 The French Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.14 The French Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.15 Top anti-smoking product sales in the Swedish market ($m), 2003-2006; Graph 9.16 The Swedish Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.17 The Swedish Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.18 Top anti-smoking product sales in the German market ($m), 2003-2006; Graph 9.19 The German Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.20 The German Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.21 Top anti-smoking product sales in the Spanish market ($m), 2003-2006; Graph 9.22 The Spanish Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.23 The Spanish Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.24 Top anti-smoking product sales in the Italian market ($m), 2003-2006; Graph 9.25 The Italian Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.26 The Italian Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.27 Top anti-smoking product sales in the Australian market ($m), 2003-2006; Graph 9.28 The Australian Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.29 The Australian Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 9.30 Top anti-smoking product sales in the Japanese market ($m), 2003-2006; Graph 9.31 The Japanese Anti-Smoking Market Revenue Forecast ($m), 2007-2012; Graph 9.32 The Japanese Anti-Smoking Market Growth Forecast (%), 2007-2012; Graph 10.1 GSK’s Company Results ($bn), 2006; Graph 10.2 J&J’s Company Results ($bn), 2006; Graph 10.3 Pfizer’s Company Results ($bn), 2005; Graph 10.4 Novartis’ Company Results ($bn), 2006; Graph 10.5 Watson’s Company Results ($bn), 2005; Graph 10.6 Takeda’s Company Results ($bn), 2006
List of Charts: Chart 7.1 Diagram showing the conversion of nicotine into cotinine; Chart 8.1 Anti-Smoking Therapy Market Share (%), 2006; Chart 8.2 Anti-Smoking Therapy Market Share (%), 2009; Chart 8.3 Anti-Smoking Therapy Market Share (%), 2012

Other users found this report page using the following search terms: smoking addiction chantix smoking graphs market graph cessation ban global nicotine 2007 uk

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster

Credit Card Details

Invoice Details

Table of Contents